# An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke

> **NCT02229890** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 593 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** alteplase

## Key facts

- **NCT ID:** NCT02229890
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 593 (ACTUAL)
- **Last updated:** 2014-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229890, "An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02229890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*